p75NTR: Key Functions in Neuronal Survival and Growth

p75NTR is a receptor protein found on the surface of neurons that acts as a molecular switch, capable of promoting either cell survival or cell death depending on which partners it teams up with and which signals it receives. Discovered as the first known receptor for nerve growth factor (NGF), it was initially thought to play a supporting role in neuronal signaling. Decades of research have revealed something far more interesting: p75NTR sits at the center of a tug-of-war between life and death signals in the nervous system, and its influence extends well beyond the brain into metabolism, immune regulation, and even cancer biology.

A Receptor With Two Faces

Most receptors in biology do one thing. They bind a molecule and trigger a predictable response. p75NTR breaks that mold. It belongs to the tumor necrosis factor receptor superfamily, a family of proteins often associated with inflammation and programmed cell death. Like its relatives TNF-R1 and Fas, p75NTR carries a “death domain” in its intracellular tail, a region that can recruit the molecular machinery needed to kill the cell from within.¹ But unlike those relatives, p75NTR can also activate survival pathways. It turns on NF-κB, a signaling molecule that protects cells from dying, and can also engage the Akt pathway, which promotes growth and survival.² Whether p75NTR pushes a neuron toward life or death depends heavily on its context: which co-receptors are present on the cell surface, which form of neurotrophin is doing the binding, and what other signals the cell is receiving at the same time.

How Co-Receptors Tip the Balance

The most consequential partnership p75NTR forms is with the Trk family of receptor tyrosine kinases, particularly TrkA. When p75NTR and TrkA are both present on a neuron, they form a physical complex that binds NGF with much higher affinity than either receptor alone. This was discovered roughly thirty years ago and remains one of the more intriguing puzzles in the field: despite extensive structural and functional research, the precise mechanism by which p75NTR enhances TrkA’s binding affinity is still not fully understood.³ What is clear is that the interaction is reciprocal: liganded and unliganded p75NTR can push TrkA into a higher-affinity state, while TrkA shifts p75NTR into a lower-affinity state. These receptor complexes exist even before NGF arrives, waiting to capture the growth factor when it does.⁴ The result, when mature NGF binds this complex, is a strong survival signal driven primarily through TrkA.

The picture darkens when p75NTR pairs with a different co-receptor called sortilin. This combination creates a high-affinity binding site not for mature neurotrophins but for their unprocessed precursor forms, known as proneurotrophins. ProNGF, for instance, binds the p75NTR-sortilin complex and triggers apoptosis, the orderly self-destruction of the cell.⁵ So the same neurotrophic factor family that sustains neurons through one receptor pairing can kill them through another. The cell’s fate hinges on which co-receptor p75NTR finds itself next to and whether the arriving neurotrophin has been properly processed into its mature form.

Survival Signaling Through NF-κB

When conditions favor survival, p75NTR activates a pathway centered on NF-κB, a transcription factor that turns on genes involved in cell protection and inflammation resistance. In developing sensory neurons, blocking NGF’s ability to bind p75NTR prevented NF-κB activation and reduced the survival effect of NGF by a measurable degree, roughly matching the reduction seen when NF-κB was blocked directly by other means.⁶ This established that p75NTR provides a genuine survival boost on top of the well-known survival signaling through TrkA. The receptor’s intracellular tail recruits adaptor proteins such as TRAF6, RIP2, and FAP-1 to carry out this protective work.²

On the death side of the ledger, different adaptor proteins are recruited: NRAGE, NADE, and NRIF, each with connections to the cell’s apoptotic machinery.² The death domain of p75NTR is unusually versatile compared to related receptors, forming a wider variety of protein-protein interactions than had been seen previously in the superfamily.¹ This structural flexibility is likely what allows p75NTR to serve as a platform for such divergent outcomes.

Cutting the Receptor to Send a Signal

One of the more surprising features of p75NTR signaling is that the receptor itself gets chopped up as part of the process. When neurotrophins bind, an enzyme called α-secretase first clips off the extracellular portion, leaving a stub in the membrane. Then γ-secretase, the same enzyme implicated in Alzheimer’s disease pathology, makes a second cut within the membrane to release the intracellular domain (ICD) into the cell interior.⁷ This freed ICD fragment is not simply debris. In the context of survival signaling, it can enhance TrkA signaling. In the context of death signaling, the γ-secretase cleavage is essential: it triggers a chain of events in which the adaptor protein NRIF gets tagged for destruction and shuttled into the nucleus, where it activates genes that execute apoptosis. Blocking γ-secretase prevented receptor cleavage, kept NRIF out of the nucleus, and blocked cell death, while forcing the ICD to be released on its own was enough to cause apoptosis in sympathetic neurons.⁸

Pruning Axons During Development

During embryonic and early postnatal development, far more neural connections are formed than the adult brain ultimately retains. The nervous system refines itself by eliminating weaker or less-active connections, a process called axon pruning. p75NTR plays a direct role in this competitive elimination. In the developing sympathetic nervous system, axons from different neurons compete for territory in target organs such as the eye. Research showed that the “winning” axons, the ones with more electrical activity, secrete brain-derived neurotrophic factor (BDNF), which then binds p75NTR on nearby “losing” axons. Rather than nurturing those axons, BDNF-p75NTR signaling causes them to degenerate by suppressing TrkA-mediated survival signaling. The losing axons, which are enriched in p75NTR, essentially receive a self-destruct signal from their more successful neighbors.⁹

Beyond pruning, p75NTR also regulates axon growth in the opposite direction. It is required for the activity of several growth cone collapsing factors, including Nogo, MAG, and OMgP, molecules that are found on myelin and normally prevent axons from growing where they should not. p75NTR associates with the Nogo receptor and transmits the inhibitory signal that causes advancing growth cones to stall or retract.¹⁰ This makes p75NTR a gatekeeper for axonal navigation: it helps determine where axons can and cannot go, both during development and after injury.

Peripheral Nerve Injury and Recovery

When a peripheral nerve is damaged, Schwann cells, the glial cells that wrap and insulate peripheral axons, massively increase their production of p75NTR. For years, researchers assumed this upregulation was critical for nerve regeneration. More recent evidence complicates that story. Mice engineered to lack p75NTR specifically in Schwann cells showed no deficits in axonal regrowth or remyelination after a sciatic nerve crush injury. The density of regenerating nerve fibers, axon diameter, and myelin thickness all looked normal. What did suffer was the speed of signal conduction: motor nerve conduction velocity recovered more slowly when Schwann cells lacked p75NTR.¹¹ The structural regrowth happened fine, but the quality of the rebuilt connection was impaired.

In the spinal cord, p75NTR on Schwann cells appears to play a restricting rather than supporting role. After dorsal root injury, Schwann cell p75NTR essentially sequesters neurotrophins, limiting their availability to regenerating axons and preventing sensory nerve fibers from spontaneously regrowing into the spinal cord.¹² This suggests that Schwann cell p75NTR may act as a biological brake on central nervous system reinnervation, a finding with implications for spinal cord injury research. The overall picture is that p75NTR in the peripheral nervous system is not simply “good for regeneration.” Its effects depend on where it sits, whether on the neuron or the glial cell, and on the specific type of recovery being measured.

Brain Injury and Neurodegeneration

In the healthy adult brain, p75NTR expression is relatively low compared to the developing brain. But after traumatic brain injury, it gets reactivated. Neurons in the injury penumbra, the vulnerable zone surrounding the primary damage site, begin expressing p75NTR again, and those neurons undergo apoptosis.¹³ In tandem, levels of proneurotrophins rise in the injured tissue, creating the deadly combination of death-inducing ligand and death-signaling receptor. This re-emergence of a developmental signaling pathway in the injured adult brain is one of the reasons secondary brain damage can continue expanding for days after an initial trauma.

The cholinergic neurons of the basal forebrain, which project widely into the cortex and are essential for memory and attention, are particularly sensitive to p75NTR-mediated damage. After cortical brain injury in mice, these neurons degenerate retrogradely, meaning the damage travels backward from the injured cortex along the axon to the cell body. Mice lacking p75NTR were protected from this retrograde neuronal loss, directly demonstrating that the degeneration depends on the receptor.¹⁴ Even without injury, these cholinergic neurons shrink with age. By 18 months in mice (roughly equivalent to late middle age in humans), cholinergic cell area in the basal forebrain had decreased by about 25%, progressing to roughly 34% shrinkage by 25 months.¹⁵

In Alzheimer’s disease, p75NTR acts as a receptor for amyloid-beta, the peptide that aggregates into the plaques characteristic of the disease, and mediates some of its toxic effects on neurons.¹⁶ In amyotrophic lateral sclerosis (ALS), a similar pattern emerges: motor neurons that express p75NTR are vulnerable to death driven by elevated NGF produced by reactive astrocytes surrounding them.¹⁷ In both diseases, the receptor that once helped developing neurons survive becomes a liability for aging and diseased ones.

Therapeutic Strategies Targeting p75NTR

Because p75NTR sits at the crossroads of survival and death in so many neurological contexts, it has become an attractive drug target. The challenge is specificity: you want to block the death-promoting activity without shutting down the survival-promoting activity. One approach that has gained traction involves small molecule ligands that bind directly to p75NTR and shift its signaling away from degenerative pathways and toward protective ones. The compound LM11A-31, developed specifically for this purpose, has shown the ability to reverse cholinergic neurite dystrophy in Alzheimer’s disease mouse models, even when treatment began at mid-to-late stages of disease progression.¹⁸ The same compound has been explored in a Huntington’s disease mouse model, where researchers used neuroimaging and biofluid biomarkers to assess whether LM11A-31’s effects could be tracked noninvasively, a necessary step toward clinical use.¹⁹

A different neuroprotective strategy involves disrupting the death-signaling receptor complex rather than modulating p75NTR directly. Low doses of lithium citrate prevented the p75NTR-sortilin complex from forming and being internalized into hippocampal neurons, and this was enough to protect the neurons from proNGF-induced death. The protective dose was strikingly small, just 100 nanomolar, orders of magnitude below the concentrations used in psychiatric treatment.²⁰ Rather than acting on p75NTR itself, lithium at these low doses interfered with the physical assembly of the receptor complex, stopping the death signal before it could start.

How p75NTR Travels Inside the Cell

Receptor signaling does not happen only at the cell surface. For many receptors, the real work begins after they are pulled inside the cell through endocytosis. p75NTR has two distinct internalization routes. Without neurotrophins bound, it enters the cell through a pathway that does not involve the protein clathrin. When neurotrophins bind, the receptor switches to clathrin-mediated endocytosis, and this switch is essential for sorting the receptor-containing vesicles onto the axonal retrograde transport pathway that carries them back to the cell body.²¹ Once the neurotrophin-p75NTR cargo arrives at the cell body, the receptor’s phosphorylation status determines what happens next. Neurotrophins bound only to p75NTR (not to Trk receptors) are routed into degradation compartments with a significant delay compared to Trk-bound neurotrophins, and blocking phosphorylation of p75NTR altered this timing.²² The speed at which a signal gets degraded is itself a signal: a longer-lived signaling complex can sustain a different biological response than one that is quickly dismantled.

Roles Beyond the Nervous System

One of the more unexpected chapters in p75NTR biology involves metabolism. Mice lacking p75NTR are protected from diet-induced obesity. When fed a high-fat diet, these knockout mice remained lean despite eating the same amount as normal mice. The difference traced to energy expenditure: fat cells from p75NTR-deficient mice burned fat at roughly 2.4 times the normal rate, and expressed dramatically higher levels of thermogenic proteins. p75NTR normally interacts directly with a component of protein kinase A in fat cells, dampening the signaling cascade that drives fat breakdown and heat generation.²³ Transplanting white fat tissue from p75NTR-deficient mice into normal mice protected the recipients from weight gain and insulin resistance on a high-fat diet.

p75NTR also regulates how cells respond to insulin. Knockout mice showed increased insulin sensitivity even on a normal diet, with improved glucose uptake in both fat cells and muscle cells. Inside fat cells, p75NTR forms a complex with small regulatory proteins called Rab5 and Rab31 that control the trafficking of the glucose transporter GLUT4 to the cell surface.²⁴ By acting as a brake on GLUT4 delivery, p75NTR limits how much glucose a cell can absorb in response to insulin. Removing that brake produced mice with better blood sugar control. These findings have raised interest in p75NTR as a potential target for treating type 2 diabetes, though translating mouse metabolic studies to human therapies is famously difficult.

Cancer and Stem Cells

p75NTR expression shows up in several cancer types, where its role is not straightforward. In oral squamous cell carcinoma induced experimentally in rats, p75NTR-positive cells were abundant during the dysplastic (precancerous) stage but dropped sharply once the tissue became frankly cancerous and began invading surrounding tissue. The decrease in p75NTR correlated inversely with the proliferation marker PCNA, suggesting that as tumor cells committed fully to rapid growth, they shed p75NTR expression.²⁵ Whether p75NTR acts as a tumor suppressor in this context or simply marks a transient cell state is still debated. The receptor has also been identified as a marker for neural crest-derived stem cells and certain melanoma stem cells, though the functional significance of its expression in those populations varies by tissue and tumor type.

An Evolutionarily Ancient Receptor

Given the complexity of p75NTR’s signaling, it is tempting to assume this is a late evolutionary invention, something vertebrates cobbled together for their elaborate nervous systems. Genomic evidence says otherwise. Orthologs of p75NTR, along with a neurotrophin and a Trk receptor, have been identified in protostomes, the branch of animal life that includes insects and crustaceans and split from vertebrates over 500 million years ago. The presence of p75NTR in both protostomes and deuterostomes indicates that death-domain-containing members of the TNF receptor superfamily appeared very early in animal evolution, and the basic neurotrophin signaling toolkit was likely in place before the two major branches of bilateral animals diverged.²⁶ What began as a relatively simple signaling system has been repurposed and elaborated across hundreds of millions of years, acquiring new co-receptors, new adaptor proteins, and entirely new physiological roles far removed from the neurons where it was first discovered.